Beijing Tong Ren Tang Chinese Medicine Company Limited

OTCPK:BJTR.F Stock Report

Market Cap: US$965.8m

Beijing Tong Ren Tang Chinese Medicine Past Earnings Performance

Past criteria checks 2/6

Beijing Tong Ren Tang Chinese Medicine has been growing earnings at an average annual rate of 2.6%, while the Pharmaceuticals industry saw earnings growing at 0.03% annually. Revenues have been growing at an average rate of 4.3% per year. Beijing Tong Ren Tang Chinese Medicine's return on equity is 14.7%, and it has net margins of 35.4%.

Key information

2.6%

Earnings growth rate

2.6%

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth rate4.3%
Return on equity14.7%
Net Margin35.4%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Beijing Tong Ren Tang Chinese Medicine makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:BJTR.F Revenue, expenses and earnings (HKD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 231,5255404310
30 Sep 231,7216194080
30 Jun 231,9186973840
31 Mar 231,8246723660
31 Dec 221,7316463480
30 Sep 221,6056013430
30 Jun 221,4785553370
31 Mar 221,5175823430
31 Dec 211,5566083490
30 Sep 211,5045953430
30 Jun 211,4525833370
31 Mar 211,3845633240
31 Dec 201,3155423110
30 Sep 201,2464833140
30 Jun 201,1784243170
31 Mar 201,3054903400
31 Dec 191,4335563640
30 Sep 191,5055943760
30 Jun 191,5776323870
31 Mar 191,5466013780
31 Dec 181,5145813810
30 Sep 181,4665523730
30 Jun 181,4025403400
31 Mar 181,3305163350
31 Dec 171,2664903140
30 Sep 171,2124693090
30 Jun 171,1664493010
31 Mar 171,1344442840
31 Dec 161,0844202720
30 Sep 161,0634312470
30 Jun 161,0284102370
31 Mar 161,0023802390
31 Dec 159703542320
30 Sep 159393372360
30 Jun 158813202260
31 Mar 158343042160
31 Dec 147612872010
30 Sep 147332861730
30 Jun 146992671670
31 Mar 146522491560
31 Dec 136142201570
30 Sep 135301761510
30 Jun 134741541380

Quality Earnings: BJTR.F has high quality earnings.

Growing Profit Margin: BJTR.F's current net profit margins (35.4%) are lower than last year (37.3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: BJTR.F's earnings have grown by 2.6% per year over the past 5 years.

Accelerating Growth: BJTR.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: BJTR.F had negative earnings growth (-16.3%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (15.5%).

Return on Equity

High ROE: BJTR.F's Return on Equity (14.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/06/29 19:16
End of Day Share Price 2024/04/01 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Beijing Tong Ren Tang Chinese Medicine Company Limited is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yanyin ZhuChina International Capital Corporation Limited
null nullCMB International Securities Limited
Christina ChenHSBC